CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding CNS Pharmaceuticals, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 14 | 21 | +7 |
| Shares | 576.2K | 2.47M | +1.90M (+329.1%) |
| Value | $75.3K | $297.3K | +$222.1K (+295.1%) |
New holders (10)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 321,874 | $38.8K | 0.00% |
| XTX Topco Ltd | 294,919 | $35.5K | 0.00% |
| Connective Capital Management, LLC | 280,055 | $33.7K | 0.04% |
| Integrated Wealth Concepts LLC | 250,000 | $30.1K | 0.00% |
| HRT Financial LP | 156,007 | $18.0K | 0.00% |
| Two Sigma Investments, LP | 93,077 | $11.2K | 0.00% |
| MAI Capital Management | 2,000 | $241 | 0.00% |
| SBI Securities Co., Ltd. | 105 | $13 | 0.00% |
| Synergy Investment Management, LLC | 9 | $1 | 0.00% |
| Dogwood Wealth Management LLC | 1 | $0 | 0.00% |
Sold out (3)
Institutions that held CNS Pharmaceuticals, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Tower Research Capital LLC (TRC) | 16,298 | $2.13K |
| Aspire Private Capital, LLC | 400 | $52 |
| Northwestern Mutual Wealth Management Co | 1 | $0 |